Aponeurotic fibroma

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Aponeurotic fibroma | |
|---|---|
| Synonyms | Calcifying aponeurotic fibroma |
| Pronounce | N/A |
| Specialty | Orthopedic surgery, Pathology |
| Symptoms | Painless, slow-growing mass |
| Complications | N/A |
| Onset | Childhood or adolescence |
| Duration | Chronic |
| Types | N/A |
| Causes | Unknown |
| Risks | None identified |
| Diagnosis | Histopathology, Imaging studies |
| Differential diagnosis | Fibromatosis, Fibrosarcoma, Giant cell tumor |
| Prevention | N/A |
| Treatment | Surgical excision |
| Medication | N/A |
| Prognosis | Generally good, but recurrence is possible |
| Frequency | Rare |
| Deaths | N/A |
Aponeurotic fibroma, also known as juvenile aponeurotic fibroma or calcifying aponeurotic fibroma, is a rare, benign soft tissue tumor that predominantly affects children and young adults. This tumor typically arises in the palms of the hands, the soles of the feet, or near the tendons of the extremities. Despite its benign nature, aponeurotic fibroma can cause significant discomfort and functional impairment depending on its location.
Etiology and Pathogenesis[edit]
The exact cause of aponeurotic fibroma remains unknown. However, it is believed to originate from fibroblastic or myofibroblastic cells within the aponeurosis, a type of dense, fibrous connective tissue that binds muscles to bones or other tissues. There is no known genetic predisposition or environmental factor directly linked to the development of this tumor.
Clinical Presentation[edit]
Patients with aponeurotic fibroma typically present with a slow-growing, painless mass. In some cases, the tumor may cause discomfort or pain, especially when located in areas subject to pressure or movement. The size of the tumor can vary, but it generally remains small, usually less than 3 cm in diameter.
Diagnosis[edit]
The diagnosis of aponeurotic fibroma is primarily based on histological examination of the tumor. Imaging studies, such as magnetic resonance imaging (MRI) or ultrasound, can be helpful in assessing the tumor's extent and its relationship with surrounding structures but are not definitive for diagnosis. A biopsy, followed by microscopic examination, is necessary to confirm the diagnosis and rule out other soft tissue tumors.
Histopathology[edit]
Histologically, aponeurotic fibroma is characterized by a mixture of fibroblasts, myofibroblasts, and calcified zones. The tumor cells are arranged in a distinctive pattern, often described as whorled or storiform. Calcification and areas of hyalinization are commonly observed. These features help in distinguishing aponeurotic fibroma from other soft tissue tumors.
Treatment[edit]
The treatment of choice for aponeurotic fibroma is surgical excision. Complete removal of the tumor is recommended to minimize the risk of recurrence. Despite its benign nature, aponeurotic fibroma has a relatively high recurrence rate, especially if the excision is incomplete. Regular follow-up is important to monitor for recurrence, particularly in the first few years after surgery.
Prognosis[edit]
The prognosis for patients with aponeurotic fibroma is generally excellent, as it is a benign tumor with no potential for malignant transformation. However, the functional outcome may vary depending on the tumor's location and the extent of surgical excision required. Early diagnosis and complete surgical removal are key to preventing recurrence and ensuring a good functional outcome.
Epidemiology[edit]
Aponeurotic fibroma is a rare tumor, with a limited number of cases reported in the medical literature. It most commonly affects children and adolescents, with no clear gender predilection. The tumor is most frequently found in the hands and feet but can occur in any location where aponeurotic tissue is present.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

